Effect of Yifei Huatan Decoction on Relieving Airway Hyperviscosity in Asthmatic Rats with Spleen Deficiency Syndrome and Its Mechanism

Jianbin ZHAI; Hongda ZHAO; Chenliang ZHAO; Shichang YU; Zhihong CHENG; Liang ZHAO

doi:10.13422/j.cnki.syfjx.20221694

您当前的位置：

首页 >

文章列表页 >

Effect of Yifei Huatan Decoction on Relieving Airway Hyperviscosity in Asthmatic Rats with Spleen Deficiency Syndrome and Its Mechanism

更新时间：2022-07-14

- Effect of Yifei Huatan Decoction on Relieving Airway Hyperviscosity in Asthmatic Rats with Spleen Deficiency Syndrome and Its Mechanism
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 28, Issue 16, Pages: 100-108(2022)
- 作者机构：
  
  河北省中医院，石家庄 050000
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20221694
  CLC： R285.5;R966;R562.2;R256.12
- Received：16 February 2022，
  
  Published Online：24 April 2022，
  
  Published：20 August 2022
- 稿件说明：
移动端阅览
翟建宾,赵宏达,赵臣亮等.益肺化痰汤减轻哮喘脾虚证大鼠气道高黏状态的作用与机制[J].中国实验方剂学杂志,2022,28(16):100-108.

ZHAI Jianbin,ZHAO Hongda,ZHAO Chenliang,et al.Effect of Yifei Huatan Decoction on Relieving Airway Hyperviscosity in Asthmatic Rats with Spleen Deficiency Syndrome and Its Mechanism[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(16):100-108.
翟建宾,赵宏达,赵臣亮等.益肺化痰汤减轻哮喘脾虚证大鼠气道高黏状态的作用与机制[J].中国实验方剂学杂志,2022,28(16):100-108. DOI： 10.13422/j.cnki.syfjx.20221694.

ZHAI Jianbin,ZHAO Hongda,ZHAO Chenliang,et al.Effect of Yifei Huatan Decoction on Relieving Airway Hyperviscosity in Asthmatic Rats with Spleen Deficiency Syndrome and Its Mechanism[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(16):100-108. DOI： 10.13422/j.cnki.syfjx.20221694.

摘要

目的

探讨益肺化痰汤减轻哮喘脾虚证大鼠气道高黏状态的作用与机制。

方法

将55只8~9周龄、清洁级SD大鼠采用中医脾虚证复合西医哮喘动物建模方法制备哮喘脾虚证模型，造模成功后采用随机数字表法分为模型组、地塞米松组、益肺化痰汤低、中、高剂量组，另取11只SD大鼠记为正常组。地塞米松组予0.087 5 mg·kg

-1

醋酸地塞米松灌胃，益肺化痰汤低、中、高剂量组分别予0.8、1.6、3.2 g·kg

-1

益肺化痰汤流浸膏灌胃，模型组和正常组分别予10 mL·kg

-1

蒸馏水灌胃。每日1次，共8周。观察各组一般情况；酶联免疫吸附测定法（ELISA）检测各组大鼠支气管肺泡灌洗液（BALF）白细胞介素-4（IL-4）、白细胞介素-13（IL-13）、

干扰素（IFN-

）水平；苏木素-伊红（HE）染色观察大鼠肺组织病理改变；阿尔辛蓝-过碘酸雪夫（AB-PAS）染色观察大鼠气道杯状细胞增生与黏液分泌状况；实时荧光定量聚合酶链式反应（Real-time PCR）检测大鼠肺组织转化生长因子-

（TGF-

）、Smad2、Smad3、黏蛋白5AC（MUC5AC）、黏蛋白5B（MUC5B） mRNA表达；蛋白免疫印迹法（Western blot）检测大鼠肺组织TGF-

、Smad2、Smad3、MUC5AC、MUC5B蛋白表达。

结果

与正常组比较，模型组大鼠存在体质量下降、肌肉消瘦、食量减少、饮水增多、肛温升高、倦怠少动及游泳耐力下降等脾虚证症状，同时伴随喘促、点头等呼吸困难症状。与正常组比较，模型组大鼠BALF中IL-4和IL-13水平显著上升，IFN-

水平显著下降（

0.01），气道黏膜层及黏膜下层见大量炎性细胞浸润、气管平滑肌明显增厚、黏膜处存在大量上皮细胞增生、变形及脱落现象，肺组织病理评分显著上升（

0.01），气道可见大量杯状细胞增生、且形成大量黏液栓，气道阳性相对着色面积、TGF-

、Smad2、Smad3、MUC5AC、MUC5B mRNA和蛋白质相对表达量显著上升（

0.01）；与模型组比较，地塞米松组和益肺化痰汤各剂量组BALF中IL-4、IL-13水平下降，IFN-

水平上升（

0.05，

0.01），气道黏膜层及黏膜下层炎性细胞浸润逐渐减少、气管平滑肌增厚现象逐渐减少、黏膜处上皮细胞增生、变形及脱落现象逐渐减少，肺组织病理评分显著下降（

0.01），气道杯状细胞增生逐渐减轻，气道阳性相对着色面积、TGF-

、Smad2、Smad3、MUC5AC、MUC5B mRNA和蛋白表达下降（

0.05，

0.01）；与地塞米松组比较，益肺化痰汤低剂量组上述指标差异无统计学意义，益肺化痰汤中、高剂量组改善更明显（

0.05，

0.01）；上述指标改善益肺化痰汤各剂量组呈剂量依赖性。

结论

益肺化痰汤可减轻哮喘脾虚证大鼠气道高黏状态，可能与抑制TGF-

、Smad2、Smad3、MUC5AC、MUC5B表达，下调IL-4和IL-13水平，上调IFN-

水平相关。

Abstract

Objective

To explore the effect of Yifei Huatan decoction on relieving airway hyperviscosity in asthmatic rats with spleen deficiency syndrome and its mechanism.

Method

Fifty-five SPF level SD rats at 8-9 week of age were used to induce asthma with spleen deficiency syndrome by animal modeling of traditional Chinese medicine combined with asthma of western medicine. After successful modeling， the rats were divided into model group， dexamethasone group， low， medium， and high-dose Yifei Huatan decoction groups by random number table method， and 11 clean SD rats at 8-9 week of age were recorded as a normal group. Rats in the dexamethasone group were given 0.087 5 mg kg

-1

dexamethasone acetate by gavage. Rats in the low， medium， and high-dose Yifei Huatan decoction groups were given 0.8， 1.6， 3.2 g kg

-1

Yifei Huatan decoction liquid extract by gavage， respectively. Rats in the model group and the normal group were given 10 mL kg

-1

distilled water. The medicine were given once per day for 8 w， and the general situation of each group was observed. The levels of interleukin-4 （IL-4）， IL-13， and interferon-

（IFN-

） in bronchoalveolar lavage fluid （BALF） were determined by enzyme-linked immunosorbent assay （ELISA）. The pathological changes in lung tissues of rats were observed by hematoxylin-eosin （HE） staining. Alcian blue-periodic acid Schiff （AB-PAS） staining was used to detect the hyperplasia of airway goblet cells and mucus secretion in rats. The mRNA expressions of transforming growth factor-

（TGF-

）， Smad2， Smad3， mucin 5AC （MUC5AC）， and mucin 5B （MUC5B） in the lung tissues of rats were detected by real-time quantitative polymerase chain reaction （Real-time PCR）. The protein expressions of TGF-

， Smad2， Smad3， MUC5AC， and MUC5B in the lung tissues of rats were detected by Western blot.

Result

As compared with the normal group， rats in the model group showed the symptoms of spleen deficiency syndrome， such as decreased body weight， muscle emaciation， decreased food intake， increased water intake， increased anal temperature， tiredness， and decreased swimming endurance， accompanied by dyspnea symptoms such as wheezing and nodding. As compared with the normal group， IL-4 and IL-13 levels in the BALF of the model group were significantly increased （

0.01）， while the IFN-

level was significantly decreased （

0.01）. In the model group， a large number of inflammatory cells were observed in the mucosa and submucosa of the airway， and the smooth muscle of the trachea was significantly thickened. The hyperplasia， deformation， and exfoliation of various epithelial cells were observed in the mucosa， and the pathological scores of lung tissue increased significantly （

0.01） in the model group. A large number of goblet cells were observed in the airway with the formation of plenty of mucous thrombus in the model group， and the positive relative staining area of airway， and mRNA and protein expressions of TGF-

， Smad2， Smad3， MUC5AC， and MUC5B were significantly increased （

0.01）. As compared with the model group， IL-4 and IL-13 levels in BALF of the dexamethasone group and the Yifei Huatan decoction groups decreased， while the IFN-

level increased. The inflammatory cell infiltration in airway mucosa and submucosa， the thickening of tracheal smooth muscle， the hyperplasia， deformation， and exfoliation of epithelial cells in mucosa were gradually decreased， and the pathological scores of lung tissues decreased significantly （

0.01） in the dexamethasone group and the Yifei Huatan decoction groups. Goblet cell proliferation gradually decreased， and the positive relative staining area of airway， and mRNA and protein relative expressions of TGF-

， Smad2， Smad3， MUC5AC， and MUC5B decreased with statistically significant difference （

0.05，

0.01）. There was no significant difference in the above indexes in the dexamethasone group and the Yifei Huatan decoction low-dose group. The above indexes were dose-dependent in the low， medium， and high-dose Yifei Huatan decoction groups.

Conclusion

Yifei Huatan decoction reduces airway hyperviscosity in asthmatic rats with spleen deficiency syndrome， which may be related to the inhibition of TGF-

， Smad2， Smad3， MUC5AC， and MUC5B expressions， down-regulation of IL-4 and IL-13 levels， and up-regulation of IFN-

level.

关键词

Keywords

references

廖小刚，朱爱勇，王欣国，等 . 中国成人哮喘患病率的Meta分析［J］. 中国循证医学杂志， 2020 ， 20 （ 10 ）： 1164 - 1172 .

周舒，黄嘉，梁雅丽，等 . 中国儿童哮喘患病率及其危险因素的Meta分析［J］. 国际流行病学传染病学杂志， 2020 ， 47 （ 3 ）： 253 - 259 .

SHASTRI M D ， CHONG W C ， DUA K ， et al . Emerging concepts and directed therapeutics for the management of asthma：Regulating the regulators ［J］. Inflammopharmacology ， 2021 ， 29 （ 1 ）： 15 - 33 .

李成辉，任宝琦，黄镛 . 支气管哮喘中医证候的现代文献研究［J］. 中国中医急症， 2021 ， 30 （ 5 ）： 790 - 792 .

白焕强，王淑萍 . 益肺化痰汤加减治疗脾肺气虚证喘证疗效观察［J］. 中国中医急症， 2018 ， 27 （ 8 ）： 1451 - 1453 .

CELLAT M ， KUZU M ， İŞLER C T ， et al . Tyrosol improves ovalbumin （OVA）-induced asthma in rat model through prevention of airway inflammation ［J］. Naunyn Schmiedebergs Arch Pharmacol ， 2021 ， 394 （ 10 ）： 2061 - 2075 .

GE Y ， CHENG R ， SUN S ， et al . Fangxiao formula alleviates airway inflammation and remodeling in rats with asthma via suppression of transforming growth factor- β /Smad3 signaling pathway ［J］. Biomed Pharmacother ， 2019 ， 119 ： 109429 .

CAMPBELL L ， HEPWORTH M R ， WHITTINGHAM-DOWD J ， et al . ILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites ［J］. J Exp Med ， 2019 ， 216 （ 12 ）： 2714 - 2723 .

国家药典委员会 . 中华人民共和国药典：一部［M］. 北京：中国医药科技出版社， 2020 .

杨华，田萌，米烈汉 . 益肺化痰汤治疗支气管哮喘非急性发作期37例［J］. 陕西中医， 2016 ， 37 （ 2 ）： 208 - 209 .

姜宇珺，张北雪，马善鹏，等 . 4种不同来源的苍术和白术对偏于实证的脾虚大鼠药效学比较研究［J］. 中华中医药学刊， 2020 ， 38 （ 8 ）： 142 - 146 .

史琦，李春雷，孔艳华，等 . SD大鼠哮喘模型建立方法及评价的比较研究［J］. 世界中医药， 2019 ， 14 （ 11 ）： 2887 - 2892 .

UNDERWOOD S ， FOSTER M ， RAEBURN D ， et al . Time-course of antigen-induced airway inflammation in the guinea-pig and its relationship to airway hyperresponsiveness ［J］. Eur Respir J ， 1995 ， 8 （ 12 ）： 2104 - 2113 .

KUMAR A ， LORAND D . Robust ΔΔct estimate ［J］. Genomics ， 2021 ， 113 （ 1 Pt 1 ）： 420 - 427 .

JOHANSSON H ， MERSHA T B ， BRANDT E B ， et al . Interactions between environmental pollutants and genetic susceptibility in asthma risk ［J］. Curr Opin Immunol ， 2019 ， 60 ： 156 - 162 .

LOMMATZSCH M ， BUHL R ， KORN S . The treatment of mild and moderate asthma in adults ［J］. Dtsch Arztebl Int ， 2020 ， 117 （ 25 ）： 434 - 444 .

吴瑞，李秀敏，苗明三 . 基于中西医临床病证特点的哮喘动物模型分析［J］. 中药药理与临床， 2020 ， 36 （ 2 ）： 253 - 257 .

RODRIGUEZ-MARTINEZ C E ， SOSSA-BRICEÑO M P ， CASTRO-RODRIGUEZ J A . Dexamethasone or prednisolone for asthma exacerbations in children：A cost-effectiveness analysis ［J］. Pediatr Pulmonol ， 2020 ， 55 （ 7 ）： 1617 - 1623 .

王利红，张影，兰坤，等 . 黄芪多糖对哮喘模型小鼠肺组织炎症的抑制作用及其机制［J］. 吉林大学学报：医学版， 2019 ， 45 （ 2 ）： 313 - 318，后插4.

闫伟华，常静侠 . 黄芪多糖对哮喘大鼠气道炎症及肺组织血管内皮生长因子表达的影响［J］. 中国临床药理学杂志， 2020 ， 36 （ 8 ）： 953 - 955 .

MOLITORISOVA M ， SUTOVSKA M ， KAZIMIEROVA I ， et al . The anti-asthmatic potential of flavonol kaempferol in an experimental model of allergic airway inflammation ［J］. Eur J Pharmacol ， 2021 ， 891 ： 173698 .

胡蔚，李岚 . 枇杷叶提取物对卵清蛋白诱导的哮喘小鼠气道炎症和气道重塑的影响［J］. 中国现代应用药学， 2021 ， 38 （ 1 ）： 20 - 27 .

翟建宾，赵亮，于士昌，等 . 桑苏饮调控TLR4通路抑制哮喘大鼠气道炎症［J］. 中国实验方剂学杂志， 2021 ， 27 （ 14 ）： 21 - 28 .

YU J ， LI K ， XU J . Indoor PM 2.5 from coal combustion aggravates ovalbumin-induced asthma-like airway inflammation in BALB/c mice ［J］. Am J Physiol Lung Cell Mol Physiol ， 2019 ， 317 （ 1 ）： L29 - L38 .

张鹤，张沄，王宋平 . 1，25-二羟维生素D 3 通过TGF- β 1 /（Smad2/3）影响的ROS调节气道重塑［J］. 天津医药， 2020 ， 48 （ 4 ）： 267 - 270，236 .

DONG L ， WANG Y ， ZHENG T ， et al . Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice ［J］. Stem Cell Res Ther ， 2021 ， 12 （ 1 ）： 4 .

WANG A ， ZHANG Q ， WANG Y ， et al . Inhibition of Gabrp reduces the differentiation of airway epithelial progenitor cells into goblet cells ［J］. Exp Ther Med ， 2021 ， 22 （ 1 ）： 720 .

程丹，陈恒睿，王梦玫，等 . 白细胞介素-13对人支气管上皮细胞SPDEF表达的影响及SPDEF在哮喘气道黏液高分泌中的作用［J］. 临床内科杂志， 2020 ， 37 （ 1 ）： 53 - 56 .

商玉立，郭彩霞，石红梅，等 . 黄芪多糖对哮喘小鼠气道炎症启动因子TSLP和DCs表达的影响［J］. 中国抗生素杂志， 2021 ， 46 （ 7 ）： 711 - 716 .

黄思捷，王嵩，郁兰，等 . 黄芪甲苷Ⅳ对哮喘小鼠Th2转录因子表达的抑制作用［J］. 现代免疫学， 2020 ， 40 （ 1 ）： 28 - 33 .

王重阳，姜京植，李俊峰，等 . 隐丹参酮通过TWEAK/Fn14和TGF- β 1 /Smads信号通路缓解OVA诱导哮喘小鼠气道炎症［J］. 中国药理学通报， 2019 ， 35 （ 8 ）： 1149 - 1154 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Comprehensive Evaluation of Zhichuanling Oral Liquid in Treatment of Asthma and Considerations for Cultivating High-value Patents

Attenuation of Airway Inflammation and Airway Remodeling in Ovalbumin Asthmatic Rats by Artemisinin through PI3K/Akt Signaling Pathway

Modified Wuhutang Alleviates Airway Inflammation and Down-regulates Expression of Muc5AC， STAT3， NF-κB， and NLRP3 in Lung Tissues of RSV-infected Asthmatic Mice

Mashao Pingchuan Decoction Inhibites Autophagy in Airway Epithelial Cells Through PI3K/Akt/mTOR Signaling Pathway

Mechanism of Combination of Pungent Dispersing Bitter Evacuant in Treatment of Asthma Based on Theory of Five Flavor Compatibility

Related Author

YANG Shuo

LI Haiyan

XIE Yanming

WANG Lianxin

CHENGFENG Jingming

CUI Xin

LI Lixun

WANG Yanmei

Related Institution

Institute of Information on Traditional Chinese Medicine，China Academy of Chinese Medical Sciences

Institute of Basic Research in Clinical Medicine，China Academy of Chinese Medical Sciences

Henan Provincial Hospital of Traditional Chinese Medicine（TCM）/Second Affiliated Hospital of Henan University of TCM

Putuo Hospital， Shanghai University of TCM

Children's Hospital of Shanghai， Children's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰